Terms: = Liver cancer AND ATM, TELO1, 472, ENSG00000149311, TEL1, ATD, ATE, DKFZp781A0353, AT1, Q13315, MGC74674, ATDC, ATC, ATA AND Prognosis
41 results:
1. Hepatitis B surface antigen positivity is associated with poor short- and long-term outcomes in patients with diffuse large B-cell lymphoma who received CHOP or R-CHOP.
Zhan Z; Guo W; Wan X; Wang B; Li J; Wang H; Li Z; Huang Y; Young KH; Bai O
Front Immunol; 2024; 15():1324113. PubMed ID: 38318173
[TBL] [Abstract] [Full Text] [Related]
2. Targeting DDX11 promotes PARP inhibitor sensitivity in hepatocellular carcinoma by attenuating BRCA2-RAD51 mediated homologous recombination.
Cao K; Wang R; Li L; Liao Y; Hu X; Li R; Liu X; Xiong XD; Wang Y; Liu X
Oncogene; 2024 Jan; 43(1):35-46. PubMed ID: 38007537
[TBL] [Abstract] [Full Text] [Related]
3. A novel prognostic model based on AFP, tumor burden score and Albumin-Bilirubin grade for patients with hepatocellular carcinoma undergoing radiofrequency ablation.
Huang J; Cui W; Xie X; Lin K; Jin D; Xie X; Zhuang B
Int J Hyperthermia; 2023; 40(1):2256498. PubMed ID: 37733400
[TBL] [Abstract] [Full Text] [Related]
4. Exome Sequencing of Paired Colorectal Carcinomas and Synchronous liver Metastases for prognosis and Therapy Prediction.
Hlaváč V; Červenková L; Šůsová S; Holý P; Liška V; Vyčítal O; Šorejs O; Fiala O; Daum O; Souček P
JCO Precis Oncol; 2023 May; 7():e2200557. PubMed ID: 37141551
[TBL] [Abstract] [Full Text] [Related]
5. Treatment and prognosis of Fibrolamellar Hepatocellular Carcinoma: a Systematic Review of the Recent Literature and Meta-analysis.
Glavas D; Bao QR; Scarpa M; Ruffolo C; Brown ZJ; Pawlik TM; Spolverato G
J Gastrointest Surg; 2023 Apr; 27(4):705-715. PubMed ID: 36797535
[TBL] [Abstract] [Full Text] [Related]
6. Genomic landscape of Chinese patients with hepatocellular carcinoma using next-generation sequencing and its association with the prognosis.
Yang Z; Liu J; Xue F; Zhang L; Xue H; Wu Y; Bai S; Du F; Wang X; Deng W; Song C; Wang K
Ann Hepatol; 2023; 28(2):100898. PubMed ID: 36634747
[TBL] [Abstract] [Full Text] [Related]
7. Precision oncology for intrahepatic cholangiocarcinoma in clinical practice.
Tomczak A; Springfeld C; Dill MT; Chang DH; Kazdal D; Wagner U; Mehrabi A; Brockschmidt A; Luedde T; Naumann P; Stenzinger A; Schirmacher P; Longerich T
Br J Cancer; 2022 Nov; 127(9):1701-1708. PubMed ID: 35986087
[TBL] [Abstract] [Full Text] [Related]
8. Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma.
Rimini M; Macarulla T; Burgio V; Lonardi S; Niger M; Scartozzi M; Rapposelli IG; Aprile G; Ratti F; Pedica F; Verdaguer H; Nappo F; Nichetti F; Lai E; Valgiusti M; Cappetta A; Febregat C; Fassan M; De Braud F; Puzzoni M; Frassineti GL; Simionato F; De Cobelli F; Aldrighetti L; Fornaro L; Cascinu S; Casadei-Gardini A
Eur J Cancer; 2022 Aug; 171():232-241. PubMed ID: 35749808
[TBL] [Abstract] [Full Text] [Related]
9. Circulating Clusterin Levels and cancer Risk: A Systematic Review and Meta-Analysis.
Beheshti Namdar A; Kabiri M; Mosanan Mozaffari H; Aminifar E; Mehrad-Majd H
Cancer Control; 2022; 29():10732748211038437. PubMed ID: 35465749
[TBL] [Abstract] [Full Text] [Related]
10. Pathogenic atm Variant-Harbouring Well-Differentiated Aggressive Type 1 Gastric Neuroendocrine Tumour with High-grade Features (G3 NET): a New Addition to the Clinical and Pathological Spectrum of Gastric Neuroendocrine Neoplasms.
Nassereddine H; Chicaud M; Rebah K; Théou-Anton N; Sautet A; Dermer J; Couvelard A
Endocr Pathol; 2021 Dec; 32(4):517-523. PubMed ID: 34019237
[TBL] [Abstract] [Full Text] [Related]
11. Surgical resection significantly promotes the overall survival of patients with hepatocellular carcinoma: a propensity score matching analysis.
Chen YS; Hsieh PM; Lin HY; Hung CM; Lo GH; Hsu YC; Lu IC; Lee CY; Wu TC; Yeh JH; Hsiao P; Li YC; Wang YC; Hsieh KC; Lin CW
BMC Gastroenterol; 2021 May; 21(1):220. PubMed ID: 33990184
[TBL] [Abstract] [Full Text] [Related]
12. The Prevalence, Associated Factors for Lung Metastases Development and prognosis in Ovarian Serous cancer Based on SEER Database.
Cao C; Yang X
Technol Cancer Res Treat; 2020; 19():1533033820983801. PubMed ID: 33356997
[TBL] [Abstract] [Full Text] [Related]
13. Identification of prognostic biomarkers and correlations with immune infiltrates among cGAS-STING in hepatocellular carcinoma.
Qi Z; Yan F; Chen D; Xing W; Li Q; Zeng W; Bi B; Xie J
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33006365
[TBL] [Abstract] [Full Text] [Related]
14. Impact of perioperative allogeneic blood transfusion on the long-term prognosis of patients with different stage tumors after radical resection for hepatocellular carcinoma.
Peng T; Wang L; Cui H; Li X; Liu M; Yu J; Wu J; Zhao G; Liu Z
Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):620-627. PubMed ID: 32988700
[TBL] [Abstract] [Full Text] [Related]
15. Tonicity-responsive enhancer-binding protein promotes stemness of liver cancer and cisplatin resistance.
Lee JH; Suh JH; Kang HJ; Choi SY; Jung SW; Lee-Kwon W; Park SA; Kim H; Ye BJ; Yoo EJ; Jeong GW; Park NH; Kwon HM
EBioMedicine; 2020 Aug; 58():102926. PubMed ID: 32739873
[TBL] [Abstract] [Full Text] [Related]
16. Hypernatremia at admission predicts poor survival in patients with terminal cancer: a retrospective cohort study.
Seo MS; Hwang IC; Jung J; Lee H; Choi JH; Shim JY
BMC Palliat Care; 2020 Jul; 19(1):94. PubMed ID: 32611346
[TBL] [Abstract] [Full Text] [Related]
17. Screening and verification of microRNA promoter methylation sites in hepatocellular carcinoma.
Ni X; Lin Z; Dai S; Chen H; Chen J; Zheng C; Wu B; Ao J; Shi K; Sun H
J Cell Biochem; 2020 Jul; 121(7):3626-3641. PubMed ID: 32065423
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic values of microRNA-130 family expression in patients with cancer: a meta-analysis and database test.
Peng Z; Duan F; Yin J; Feng Y; Yang Z; Shang J
J Transl Med; 2019 Oct; 17(1):347. PubMed ID: 31640738
[TBL] [Abstract] [Full Text] [Related]
19. MDM4 expression in fibrolamellar hepatocellular carcinoma.
Karki A; Putra J; Kim SS; Laquaglia MJ; Perez-Atayde AR; Sadri-Vakili G; Vakili K
Oncol Rep; 2019 Oct; 42(4):1487-1496. PubMed ID: 31322272
[TBL] [Abstract] [Full Text] [Related]
20. SET domain containing 1B gene is mutated in primary hepatic neuroendocrine tumors.
Yang P; Huang X; Lai C; Li L; Li T; Huang P; Ouyang S; Yan J; Cheng S; Lei G; Wang Z; Yu L; Hong Z; Li R; Dong H; Wang C; Yu Y; Wang X; Li X; Wang L; Lv F; Yin Y; Yang H; Song J; Gao Q; Wang X; Zhang S
Int J Cancer; 2019 Dec; 145(11):2986-2995. PubMed ID: 30977120
[TBL] [Abstract] [Full Text] [Related]
[Next]
